The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo

@article{Staudt2004TheTM,
  title={The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo},
  author={Michelle R. Staudt and Yogita Kanan and Joseph H. Jeong and James F. Papin and Rebecca Hines-Boykin and Dirk P. Dittmer},
  journal={Cancer Research},
  year={2004},
  volume={64},
  pages={4790 - 4799}
}
Certain lymphomas in AIDS patients, such as primary effusion lymphoma (PEL), are closely associated with the lymphotropic γ herpes virus Kaposi’s sarcoma-associated herpes virus (KSHV), also called human herpesvirus 8. The virus is thought to be essential for tumorigenesis, yet systems to investigate PEL in vivo are rare. Here we describe PEL tumorigenesis in a new xenograft model. Embedded in Matrigel, PEL cells formed rapid, well-organized, and angiogenic tumors after s.c. implantation of C.B… 
Productively Infected Murine Kaposi's Sarcoma-Like Tumors Define New Animal Models for Studying and Targeting KSHV Oncogenesis and Replication
TLDR
Two new murine models of Kaposi's sarcoma are described and it is proposed that these novel models are ideal for studying both viral and host contributions to KSHV-induced oncogenesis as well as for testing virally-targeted antitumor strategies for the treatment of KS.
Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells
TLDR
Single-cell RNA sequencing of latently infected PEL supports the existence of multiple subpopulations even within a single cell line and establishes a conceptual framework to design KSHV cure studies analogous to those for HIV.
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
TLDR
A direct xenograft model, UM-PEL-1, is developed by transferring freshly isolated human PEL cells into the peritoneal cavities of NOD/SCID mice without in vitro cell growth to show that bortezomib induces PEL remission and extends overall survival of mice bearing lymphomatous effusions.
lymphoma and Kaposi sarcoma Tumor suppressor microRNAs are underrepresented in primary effusion
TLDR
It is shown that the absence of miRNAs likewise can be used to determine tumor origin (miR155) and proliferation state, since tumor suppressor mi RNAs were significantly downregulated in primary effusion lymphoma and in Kaposi sarcoma, an endothelial cell tumor.
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
TLDR
It is demonstrated that activation of the p53 pathway using murine double minute 2 (MDM2) inhibitor Nutlin-3a conveyed specific and highly potent activation of PEL cell killing, which presents new options for exploiting reactivation of p53 as what the authors believe to be a novel and highly selective treatment modality for this virally induced lymphoma.
Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo
TLDR
KSHV-infected LTCs represent the first xenograft model for KS and should be of use to study KS pathogenesis and for the validation of anti-KS drug candidates.
Increased tumorigenicity of cells carrying recombinant human herpesvirus 8
TLDR
Whether cells carrying the HHV-8 BAC would form tumors when injected into mice was determined, enabling the use of this model to assess the influence of viral gene mutation on tumorigenesis.
The Zebrafish Xenograft Platform—A Novel Tool for Modeling KSHV-Associated Diseases
TLDR
The development of the first in vivo model for a virally induced lymphoma in zebrafish, whereby KSHV-infected PEL tumor cells engraft and proliferate in the yolk sac of zebra fish larvae, and it is found that PEL cell proliferation in xenografts was dependent on the host hypoxia-dependent translation initiation factor, eukaryotic initiation factor 4E2 (eIF4E2).
Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis.
TLDR
The understanding of the mechanisms of viral lymphomagenesis should lead to the identification of novel therapeutic targets and to the development of rationally designed therapies.
Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
TLDR
This unifying model describes the current understanding of KS pathogenesis by drawing together multiple theories of KS progression that by themselves cannot account for the complexities of tumor development.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 112 REFERENCES
De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells
TLDR
It is shown that human dermal microvascular endothelial cells immortalized by expression of telomerase can be readily infected by KSHV virions produced by PEL cells, and this behavior faithfully recapitulates the behavior of spindle cells explanted from primary KS biopsies, strongly supporting the biological relevance of this culture system.
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
TLDR
The close relationship between KS and K SHV gene expression is consistent with the hypothesis that KSHV is directly involved in the etiology and pathogenesis of KS, and detects viral gene expression in prostatic tissue, supporting a possible mechanism for sexual transmission of KSHv.
Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures
TLDR
It is demonstrated that infection with supernatant virions derived from three different tetradecanoyl phorbol acetate-induced PEL cell lines can induce cultured primary human dermal microvascular endothelial cells (DMVEC) to form colonies of proliferating latently infected spindle-shaped cells, all of which express the KSHV-encoded LANA1 protein.
Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells
TLDR
It is shown that Kaposi's sarcoma-associated herpesvirus can establish latent infection in many adherent cell lines, including human and nonhuman cells of epithelial, endothelial, and mesenchymal origin.
Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
TLDR
Investigating the biological consequences of infecting human primary endothelial cells with purified KSHV particles finds that infection causes long-term proliferation and survival of these cells, which are associated with the acquisition of telomerase activity and anchorage-independent growth.
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.
TLDR
Data suggest that AIDS-associated KS and possibly other types of KS may be initiated by signals that induce the growth of particular cells (spindle cells of lymphatic or vascular origin) and the expression of autocrine and paracrine activities.
Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53
TLDR
KSHV has tissue-specific latent gene expression programs and a new latent protein which may contribute to KSHV tumorigenesis in hematopoietic tissues via p53 inhibition is identified.
A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant
TLDR
Viral supernatant from JSC-1 was much more efficient at infecting primary human dermal microvascular endothelial cells (DMVECs) with KSHV than supernatants from BC-3 or BCP-1 PEL cell lines.
Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice
TLDR
Although no disease was evident in infected animals, SCID-hu Thy/Liv mice should allow the detailed study of KSHV tropism, latency, and drug susceptibility, suggesting that this model faithfully mimics the natural tropism of this virus.
Injection of human primary effusion lymphoma cells or associated macrophages into severe combined immunodeficient mice causes murine lymphomas.
TLDR
A potential model of murine lymphomagenesis consistent with the sequential pathogenesis model of lymphoma is discovered and could significantly impact the current thinking about posttransplantation and other immunodeficiency-related lymphoproliferative disorders.
...
1
2
3
4
5
...